Orange Book product · Brand (NDA)

QAMZOVA

MELOXICAM

Brand (NDA)NDA 217593RX NANJING DELOVA

Apr 22, 2025

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Apr 22, 2025
1 yr 2 mo ago
Today
Patent 12059423 expires
Listed drug substance patent expiration.
Jul 19, 2040
in 14 yr 3 mo

Active ingredient

MELOXICAM

Strength

30MG/ML (30MG/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 217593

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
12059423	Jul 19, 2040	in 14 yr 3 mo	SubstanceProduct